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ABSTRACT
Dysmenorrhea is a major cause of female morbidity globally. Asparagus 
racemosus (ASP) is traditionally used to manage dysmenorrhea in 
Nakuru, Kenya. This study evaluates the effect of Asparagus racemosus 
on female reproductive parameters; estrus cyclicity, mating success, 
gestation length, litter size and dysmenorrhea. The effect of Asparagus 
racemosus and ibuprofen on isolated uterine strips was evaluated using 
six non-pregnant rats. The uterine strips were exposed to serial extract 
concentrations (20, 40, 80,160 mg/ml) and 20 mg/ml ibuprofen was 
used as a positive control. 
There was significant increase of proestrus phase (P < 0.001) and 
a subsequent significant reduction in the metestrus (P < 0.01) and 
diestrus (P < 0.05). No significant difference in mating success and 
gestation length, however Ibuprofen caused significant disruption of 
gestation length (P < 0.05). The treated groups produced higher number 
of pups compared to controls. The plant extract caused a dose dependent 
significant reduction in uterine force of contraction by (-0.15%, 
-5.13%, -7.97%, -19.55 %) at 20, 40, 80 and 160 mg/ml respectively. 
The plant extract also caused a significant decline in frequency of uterine 
contraction (-5.99%; -9.61%; -16.76% and - 25.21%) The extract caused 
no mortality even at the limit dose; 5000 mg/kg. Asparagus racemosus 
reduces uterine force and frequency of contraction. This is probably the 
reason for its traditional use in dysmenorrhea management.
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INTRODUCTION
Dysmenorrhea is the major gynecological problem 
among women of reproductive age globally (Ozgoli 
et al., 2009; Proctor and Farquhar, 2006). However, 
it is usually under-diagnosed and under-treated 
and most women regard the pain as a normal 
condition of the menstrual cycle (Wong, 2011). 
Dysmenorrhea can either be primary or secondary 
(Proctor and Farquhar, 2006). Primary dysmenor-
rhea is the painful cramping of the lower abdomen 
without any identifiable pelvic pathological condi-
tion just before or during menses (De Sanctis et al., 
2016). It is associated with insomnia, mood distur-
bances and reduced daily activities (Allen and Lam, 
2012). It is widely accepted to be caused by over-
production of uterine prostaglandins (PG) leading 
to hyper-contractility of the myometrium, isch-
emia and hypoxia (Dawood, 1987). Non-Steroidal 
Anti-inflammatory Drugs (NSAIDs) and Oral 
contraceptions (OCPs) the common conventional 
treatments cause a pleiphora of side effects (Proctor 
et  al., 2001). Therefore the search for alternative 
remedies including medicinal plants is necessary.
Asparagus racemosus of family Asparagacea has 
been widely used in the management of dysmen-
orrhea. The major bioactive components present 
in the root of Asparagus racemosus are the steroi-
dal saponins, flavonoids, isoflavonoids, glyco-
sides, minerals like Calcium, Magnesium, Iron, 
Phosphorus and vitamins A, B1, B2, C, E (Shaha and 
Bellankimath., 2017; Joshi,2016). Phytoestrogenic 
activity of Asparagus racemosus is due to the steroi-
dal saponins which enables estrogen hormone 
balance (Joshi, 2016). The plant has been used to 
alleviate menstrual disorders raging from premen-
strual syndrome (Kinage and Chaudhari, 2016). 
The role of Asparagus racemosus in alleviating 
dysmenorrhea is not clear and the literature is very 
scanty. This study was aimed at elucidating effects 
of Asparagus racemosus on related estrous cyclic-
ity, pregnancy outcome and its effect on isolated 
myometrial quiescence.
MATERIALS AND METHODS
Extract preparation
The study was carried in Olenguruone area in 
Nakuru County, Kenya. The plant was collected in 
January 2019, washed and allowed to dry, then trans-
ported to the Department of Veterinary Anatomy 
and Physiology, University of Nairobi. The dried 
roots were chopped into smaller pieces using a knife, 
ground into fine powder. The voucher specimen of 
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the plant was deposited in the School of Biological 
Sciences herbarium (University of Nairobi) and 
assigned specimen number (RI2019/08). Three 
hundred grams of the powder was put in 3litres of 
boiling distilled water for about 30 minutes. The 
mixture was allowed to cool, filtered and dried in 
an oven at 45°C. The percentage yield was calcu-
lated (6.67%) and stored in a refrigerator (-20°C) 
until use. Kenyan Asparagus racemosus preliminary 
phytochemical screening was carried out following 
the method used by Periyasamy and Mahalingam 
(2010) to screen for presence of saponins, alkaloids, 
flavonoids, tannins, terpenoids and glycosides.
Experimental Animals
Female albino Wistar rats 5-6 weeks old were 
used. They were purchased from Biochemistry 
Department, University of Nairobi. Animals were 
housed in the Department of Veterinary Anatomy 
and Physiology animal house. Wood shavings 
were used as beddings and were replaced every 
other day. Animals were maintained under stan-
dard environmental conditions of 12 hour light 
and 12 dark cycles, temperatures of 24-25°C. They 
were provided with adequate rat-pellets from 
Bellmill feeds limited (Kenya) and water ad-li-
bitum. Animal welfare and Ethics clearance was 
sought from the Faculty of Veterinary Medicine 
Biosafety and Animal Ethics committee (FVM/ 
BAUEC/2019/186). Anti-plagiarism report (ID 
1154321540) was carried out by University of 
Nairobi library.
Experimental protocols
Acute oral toxicity
A total of 12 nulliparous non pregnant female rats 
were used. They were divided into groups of 3 
and the experiment was carried out following the 
OECD guideline 423. Their weights were recorded 
on day 0, 1, 7 and 14. Acute oral toxicity was done 
to determine lethal dose (LD50) and safety of the 
plant extract.
Cyclicity, mating success, gestation length and 
litter size 
A total of 20 nulliparous non pregnant normal cyclic 
female Wistar rats aged 6 weeks old were used. 
Estrus cyclicity was monitored daily 9-10am for 
20 days to ensure normalcy. The rats were divided 
into 4 groups of 5 rats each. They received Asparagus 
racemosus extract every other day for 14  days. 
Group1 (600 mg/kg) and group II (300 mg/kg) 
Asparagus racemosus root extract respectively, 
group III (20 mg/kg) ibuprofen (positive control), 
group IV (0.5ml) physiological saline (negative 
control). Vaginal flush was done daily between 9 to 
10 am for all the rats and estrus stages recorded. 
After the 14 days, males of proven fertility were 
introduced into the cages. Vaginal swabbing and 
microscopy was done daily between 8-9 am to 
determine presence or absence of spermatozoa. The 
day spermatozoa was seen was recorded as day 1 
of pregnancy, the female was put in a separate cage 
and monitored daily by weighing until they littered. 
The litter size and gestational length for all rats was 
recorded.
Preparation of uterine strips for uterine 
contractility
A total of 6 nulliparous non pregnant female 
rats aged 4 months old were used. They received 
2  mg/kg b/w intra peritoneal stilboestral injec-
tion 24 hours before the onset of the experiment. 
Immediately thereafter, the uterine horns were care-
fully harvested, excised of connective tissues and 
placed in a dish of de Jalon’s solution. De Jalon solu-
tion was a mixture of sodium chloride (9 grams), 
sodium hydrogen carbonate (2.1 grams), glucose 
(0.5 grams), potassium chloride (0.402 grams), 
calcium chloride (0.24 grams), sucrose (4.5 grams), 
sodium dihydrogen phosphate (0.142 grams) in 
a litre of distilled water. The solution was main-
tained at 35± 0.5°C and continuously bubbled with 
a mixture of 95% oxygen and 5% carbon dioxide. 
Uterine strip, 2cm in length was cut and mounted 
vertically within the organ bath with one end fixed 
and the other one attached to an isotonic force 
transducer (ML500/A, AD Instrument) coupled 
with Power Lab data acquisition system (Power 
Lab 8/30). The force of contraction (grams) and 
frequency of contraction (beats per minute) were 
recorded and analyzed using Chart5 software for 
windows. One uterine strip at a time was mounted 
in the organ bath. The uterine strip was stabilizing 
for approximately 20minutes, then negative control 
readings recorded for 10 minutes. Uterine strips 
were thereafter exposed to 20, 40, 80 and 160 mg/ml 
of the extract (Kaingu et al., 2011); beginning with 
lowest concentration (20mg/ml). The uterine strip 
was rinsed 3 times with de Jalon solution, allowed 
20 minutes recovery; then exposed to 40mg/ml 
Asparagus racemosus root extract. Contractions 
were recorded for 10 minutes. The procedure was 
repeated until the strip had been exposed to all the 
extract concentrations. The process was repeated 
six times using fresh uterine strips. The effect of 
Asparagus racemosus root extract on the frequency 
(rate) of uterine contraction as well as contrac-
tion strength (force) was recorded. The frequency 
was given by the event counts determined by 
the number of peaks in the selected region. The 
strength was given by the means of the data points 
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in the selected region over a period of 10 minutes. 
The treatment readings were compared with the 
positive and negative control recordings.
Data analysis 
Data collected was entered into MS- excel data 
sheet and cleaned. The results were recorded as 
Mean ± SEM. Data was analyzed using SPSS and 
graphs were generated using Graphpad Prism 
version 8. Descriptive statistics was carried out on 
the outcome variables. One-way ANOVA followed 
by Bonferroni post hoc test were used to compare 
the outcomes between groups. P-values (P < 0.05; 
P < 0.01; P < 0.001) were considered significant.
RESULTS
Phytochemistry and acute oral toxicity of 
Asparagus racemosus root extract
Kenyan Asparagus racemosus root extract phyto-
chemistry showed presence of saponins, flavo-
noids, terpenoids and glycosides. Alkaloids and 
tannins were absent. Animals used for the acute 
oral toxicity study showed no significant difference 
in their weight gain compared to the control group 
(P  >  0.05). Asparagus racemosus root extract did 
not cause any mortality even at the 5000 mg/kg. 
Effect of Asparagus racemosus aqueous root 
extract on estrus cyclicity, mating success, 
gestation length and litter size
Estrus cycle disruption was observed in the high 
(600 mg/kg) and low (300 mg/kg) dose group 
compared to the negative control. There was a 
significant difference (P < 0.05) in the proestrus 
phase within the treated group compared to 
control. Metestrus and diestrus phases were signifi-
cantly (P < 0.01 and P < 0.05) disrupted respectively 
compared to control group. There was no signifi-
cant difference in the estrus phase compared to 
the control groups (P > 0.05). All rats treated with 
ibuprofen had increased appearance of frequency of 
proestrus with subsequent reduction in frequency 
of metestrus and diestrus phase.
Mating success, conception, gestation and litter 
size 
Asparagus racemosus aqueous root extract at 
600  mg/kg and 300 mg/kg caused no signifi-
cant difference to mating success (100% success) 
compared to the control. All rats conceived (100%) 
compared to negative (80%) and positive control 
(40%). Asparagus racemosus root extract did not 
cause a significant difference in gestation length 
compared to the negative control. However, ibupro-
fen caused a significant difference in the gestation 
length (P  < 0.05) compared to treatment groups 
(Table 2). There was no significant difference in the 
litter size for both treatment groups compared to the 
negative and positive controls (Table 2). Only 2 rats 
in the ibuprofen treated group littered out of the 5.
Effect of Asparagus racemosus aqueous 
extract on isolated uterine strip contraction 
Percentage contraction was obtained by the 
formula (% contraction = force of contraction after 
Table 1 Effect of Asparagus racemosus aqueous root extract on estrus cyclicity.
Treatment Proestrus Estrus Metestrus Diestrus
Negative control 3.60 ± 0.4 3.4 ± 0.245 3.4 ± 0.4 3.6 ± 0.245
600 mg/kg ASP 6.00 ± 0.316** 4.00 ± 0.316 1.4 ± 0.4** 2.8 ± 0.2
300 mg/kg ASP 5.40 ± 0.6* 3.8 ± 0.2 1.8 ± 0.374* 2.8 ± 0.374
Positive control 6.20 ± 0.2** 3.60 ± 0.4 2.00 ± 0.316 2.40 ± 0.245*
P-value 0.001*** 0.543 0.009** 0.044*
Estrus cycle was monitored for 14 days. Values represent Mean ± SEM for the frequency of appearance of the various phases. 
Values with superscripts *, **, *** have a significant difference at (P < 0.05; P < 0.001; P < 0.0001) respectively compared to the 
negative control.
Table 2 Effect of Asparagus racemosus on mating success, gestation length and litter size
Treatment Mating success (%) Conception rate (%)
Gestation length 
(number)
Litter size 
(number)
Negative control 100% 80% 21.75 ± 0.25 9.75 ± 0.5
600 mg/kg ASP 100% 100% 21.80 ± 0.2* 10.60 ± 0.4
300 mg/kg ASP 100% 100% 21.80 ± 0.2* 9.80 ± 0.9
Positive control 100% 40% 23.00 ± 0.0* 7.50 ± 1.5
P-value 0.026* 0.144
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treatment ˗ control contraction, divided by control 
contraction ×100). There is significant differ-
ence in force of contraction compared to control 
(P< 0.0001). 20, 40, 80, 160 mg/ml Asparagus race-
mosus root extract reduced the percentage force of 
contraction by -0.15%; -4.87 %; -7.97% and -19.55% 
respectively. The decrease in force of contraction 
was in a dose dependent manner. Upon addition 
of Ibuprofen, the percentage decrease in uterine 
force of contraction was -13.38% compared to the 
negative control. 
The frequency of uterine contraction was simi-
larly reduced significantly (P < 0.0001). 20, 40, 
80, 160 mg/ml Asparagus racemosus root extract, 
reduced the frequency of uterine contraction by 
-5.99%, -9.61%, -16.76% and -25.21% respectively. 
A significant difference in the frequency of uterine 
contraction was at 80 and 160 mg/ml (P < 0.05 and 
P < 0.0001) respectively compared to the negative 
control. Ibuprofen caused a percentage decrease in 
the frequency of uterine contraction by -15.78%.
DISCUSSION
Asparagus racemosus root extract is used by 
traditional herbalists in Nakuru County, Kenya 
to alleviate/ manage dysmenorrhea. Preliminary 
phytochemistry of Kenyan Asparagus racemosus 
revealed presence of saponins, flavonoids, glyco-
sides and terpenoids. Glycosides and flavonoids 
(Telafo et al., 2012) promotes fertility. Justicia insu-
laris flavonoids and glycosides improved fertility 
in female rats by inducing ovarian steroidogenesis 
and folliculogenesis (Tefalo et  al., 2012). Solanum 
torvum used for its analgesic properties contain 
flavonoids, saponins, tannins and glycosides 
(Ndebia et al., 2007). These estrogenic compounds 
could probably be the reason for its use to relieve 
pain. Khatami et al., 2017 also reported presence of 
flavonoids and glycosides the main agents for anal-
gesic effect on the uterine muscle in Chamomile 
flowers which is used in treatment of dysmenor-
rhea. Acute oral toxicity studies caused no mortal-
ity even at 5000 mg/kg. Kumar et al., 2010 reported 
similar results where Asparagus racemosus caused 
no mortality at 3200 mg/kg.
Estrus cyclicity 
Asparagus racemosus root extract caused an 
increased appearance frequency of proestrus and 
estrus and subsequent reduction in appearance of 
metestrus and diestrus phases at 300 and 600 mg/kg 
respectively. This could be due to estrogenic prop-
erties of Asparagus racemosus. Estrogen levels 
increase during proestrus phase and are beneficial to 
development and maturation of follicles (Satue and 
Figure 1  The effect of Asparagus racemosus root 
extract and ibuprofen on estrus cyclicity 
for a period of 14 days (n=5)
Figure 2  The effect of Asparagus racemosus 
and Ibuprofen on force of uterine 
contraction
Figure 3  The effect of Asparagus racemosus and 
ibuprofen on frequency of uterine 
contraction
www.phytomedicine.ejournals.ca Discovery Phytomedicine 2019; 6(4): 199-204. doi: 10.15562/phytomedicine.2019.110 203
Effect of Asparagus racemosus ... Linet Mwende Kaaria, et al.
Gardon 2013). In this study, frequency of proestrus 
and estrus increased. Estradiol causes endome-
trial thickening and proliferation in preparation 
for implantation. Effect of Asparagus racemosus 
could be at pituitary or gonadal level. In late luteal 
phase of non-pregnant animals, uterine produc-
tion of prostaglandin PGF2α increases. PGF2α is 
transported to the corpus luteum (Johnson, 2002) 
and initiates luteolysis. The resultant reduction in 
progesterone and elevated PGF2α leads to dysmen-
orrhea. A decrease in appearance frequency of 
metestrus and diestrus phase probably might be 
caused by a reduction in of PGF2α. Exploration of 
this theory might be useful in generating a novel 
analgesic drug. Studies have shown that during late 
luteal phase (late stages of metestrus and diestrus) 
the levels of estradiol starts to increase and proges-
terone decrease (Walmer et al, 1992). This is when 
dysmenorrhea starts to be manifested.
Mating success, gestation length and litter 
size 
100% mating success due to Asparagus racemosus 
is probably due to increased concentration of estra-
diol that promotes follicle maturation. It also causes 
pre-ovulatory gonadotropins surge leading to 
ovulation (Smith et al., 2005). The normal gestation 
length of 21 days probably was due to presence of 
estrogenic compounds in the Asparagus racemosus 
that may mimic the normal end of gestation high 
estrogen levels compared to ibuprofen that had 
slight increased number of days. Increased litter 
size due to effect of Asparagus racemosus extract is 
probably due to its reported enhancement of follic-
ulogenesis and ovulation in Wistar rats (Kalia et al., 
2003). Asparagus racemosus is also reported to play 
a role in uterine receptivity and implantation hence 
enhancing fertility (Prasad et al., 2002). Kumar and 
Singh, (2001) reported improved conception rate of 
due to Asparagus racemosus in women under-going 
IVF compared to the placebo. The 100% mating 
success caused by ibuprofen with prolonged gesta-
tion length and only two out of five rats littering and 
decreased litter size probably was due to compro-
mised fertilization and/or implantation.
Myometrial quiescence 
The possible cause for dysmenorrhea is increased 
release of prostaglandins (PG) especially PGF2 
α which cause hyper contractility of the uterine 
muscle in turn reducing uterine blood flow hence 
causing pain (Wallace et  al., 2010). In this study, 
higher concentration of the extract caused the most 
significant reduction in the force and frequency 
of uterine contraction ranging from P < 0.01*; P 
< 0.001** to P < 0.0001*** Figure 2 and 3). These 
results corroborates other studies (Khulbe, 2015; 
Mishra et  al., 2013) that reported similar results. 
Shatavari blocked uterine contractions in the rat, 
guinea pig and rabbit in a dose dependent manner, 
hence used in the management of dysmenor-
rhea. Echinophora platyloba is reported to reduce 
uterine contractions hence its use in treatment of 
dysmenorrhea (Bahmani et  al., 2015). Achillea 
willhemsii causes anti-prostaglandin effect hence 
used to manage dysmenorrhea (Mirabi et al., 2014). 
Saraca indica treats dysmenorrhea (Mishra et  al., 
2013). Zingiber officinale treats dysmenorrhea 
and menstrual irregularities (Ozgoli et  al., 2009). 
Foeniculum vulgare inhibit uterine contractions 
induced by prostaglandins there-by minimizing 
dysmenorrhea (Shams et  al., 2005). Matricaria 
chamomilla has antispasmodic effects thus used in 
the treatment of dysmenorrhea (Barene et al., 2003). 
Peppermint oil provides antispasmodic activity 
on the uterine muscle by blocking the calcium 
channels thus used in dysmenorrhea management 
(Bahmani et al., 2015). Plants have the potential to 
generate novel dysmenorrhea drugs and so does 
Asparagus racemosus. It is therefore imperative to 
pursue alternative source of remedies for dysmen-
orrhea. Saponins, glycosides and flavonoids in the 
Asparagus racemosus aqueous root extract might 
be responsible for the fertility effect and its use in 
pain relief. Effect of Asparagus racemosus on these 
reproductive parameters shows no adverse effects 
and can be used as fertility promoter. However 
further work can be done involving testing the 
plant on other smooth muscles. Also isolation of 
pure compounds so as to establish if the activity is 
attributed to specific compounds.
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